Speaker Profile
President and CEO, Certis Oncology
Biography
Peter Ellman is the President and CEO of Certis Oncology Solutions, a precision oncology and translational science start-up established in 2016 and located in San Diego, California.A serial entrepreneur, prior to his current role Peter led Paradox Dx, a pharmacogenomics business and Nextec Applications, an advanced materials technology company. He served on the board of StrataGene, a publicly held molecular diagnostics company acquired by Agilent in 2007. He also served as founding sales executive for Thermoscan, the worlds first infra-red ear thermometer acquired by Gillette in 2003 and Interplak, an electronic consumer products company acquired by Bausch and Lomb in 1988.
Talk
Explore how AI-driven digital assistants are reshaping oncology research and drug discovery. Learn how these tools simplify access to vast datasets, streamline complex genetic and molecular data analysis, enhance predictive modeling for drug efficacy and drug repurposing, accelerate the development of personalized cancer treatments, and foster innovation in precision medicine.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Gad Getz, Broad Institute
- PMWC 2025 Luminary Award
Luminary Honoree: Jensen Huang, Nvidia
- Continued Jensen Huang, Nvidia
- Predictive Modeling for Drug Development
- Luca Emili, InSilicoTrials
- Knowledge Graphs, LLMs & Foundation Models for Enhanced Drug Development
- Janusz Dutkowski, Data4Cure
- Paul Rejto, Pfizer
- PMWC Showcase
- Peter Ellman, Certis Oncology
- Beyond LLMs: Harnessing Advanced AI Models for Genomics and Transcriptomics (PANEL)
Chair: Gad Getz, Broad Institute
- Yasin Şenbabaoğlu, CZ Biohub San Francisco
- Orly Alter, PrismAI
- Nicolo Fusi, Microsoft - Empowering AI in Precision Medicine with Federated Data Platforms
- Noah Nasser, Datma
- Advancing Global Health through Data Sharing: Practical Strategies and Success Stories (PANEL)
Chair: Luca Foschinii, Sage Bionetworks
- Peter Goodhand, GA4GH
- Karen Miga, UCSC
- Philip Awadalla, Ontario Institute for Cancer Research
- Driving Drug Discovery With Low-cost Foundational Omics Datasets
- Gilad Almogy, Ultima Genomics
- Johnny Yu, Vevo Therapeutics
- Stacie Calad-Thomson, NVDIA - Enabling Targeted Precision Drug & Gene Delivery with Predictive AI
- Andre Watson, Ligandal Inc.
- Quantum Leap: The Future of AI and Machine Learning with Quantum Computing
- Matthias Troyer, Microsoft
